MARKET

AKER

AKER

Akers
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.995
+0.525
+15.13%
Closed 19:53 07/14 EDT
OPEN
3.450
PREV CLOSE
3.470
HIGH
4.140
LOW
3.410
VOLUME
2.77M
TURNOVER
--
52 WEEK HIGH
16.32
52 WEEK LOW
1.550
MARKET CAP
24.46M
P/E (TTM)
-0.6414
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average AKER stock price target is 4.000 with a high estimate of 4.000 and a low estimate of 4.000.

EPS

AKER News

More
Akers Biosciences and Premas Biotech Announce Initiation of Animal Studies
GlobeNewswire · 07/07 14:00
Hedge Funds Are Nibbling On Akers Biosciences Inc (AKER)
Insider Monkey · 05/29 19:22
Akers Biosciences Closes $4.8 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
GlobeNewswire · 05/18 22:33
CytomX Slumps On Data, And Other News: The Good, Bad And Ugly Of Biopharma
Seeking Alpha - Article · 05/18 15:04
Akers Bio announces discounted direct stock offering
Akers Biosciences (AKER +5.1%) has agreed to sell ~1.4M common shares at $3.53 in a direct offering. Gross proceeds should be ~$4.8M. Shares were exchangin
seekingalpha · 05/14 22:20
42 Stocks Moving In Thursday's Mid-Day Session
Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) jumped 53.4% to $13.64 after the company announced it has received FDA emergency use authorization for its coronavirus diagnostic assay kit.
Benzinga · 05/14 18:57
Akers Biosciences Announces $4.8 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
GlobeNewswire · 05/14 18:00
AIM, CLLS, CRK and CGEN among midday movers
Seeking Alpha - Article · 05/14 16:40

Industry

Medical Equipment, Supplies & Distribution
+2.37%
Healthcare Equipment & Supplies
+2.31%

Hot Stocks

Symbol
Price
%Change

About AKER

Akers Biosciences, Inc. develops, manufactures, and supplies point-of-care screening and testing products designed to bring health-related information directly to the patient or clinician. The Company’s product offerings focus on delivering diagnostic assistance in a variety of healthcare fields/specialties, including diagnostic rapid manual point-of-care tests for the detection of allergic reactions to Heparin and for on- and off-the-job alcohol safety initiatives. The Company's primary focus is on the development and sale of disposable diagnostic testing devices that can be performed in minutes, to facilitate time sensitive therapeutic decisions. The Company's main products include a disposable breathalyzer test that measures the blood alcohol content of the user, a rapid test detecting the antibody causing an allergic reaction to Heparin and a disposable breathalyzer test that measures Free Radical activity in the human body.
More

Webull offers kinds of Akers Biosciences Inc stock information, including NASDAQ:AKER real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AKER stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AKER stock methods without spending real money on the virtual paper trading platform.